Federated Hermes
SGMT icon

Federated Hermes’s Sagimet Biosciences SGMT Stock Holding History

Federated Hermes’s Portfolio SGMT Stock Details SGMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.08K Buy
781
+519
+198% +$2.89K ﹤0.01% 1913
2025
Q4 		$1.55K Sell
262
-301
-53% -$2.16K ﹤0.01% 1987
2025
Q3 		$3.86K Buy
+563
New +$4.57K ﹤0.01% 1966
2024
Q4 		– Sell
-60,000
Closed -$166K – 2177
2024
Q3 		$166K Sell
60,000
-8,000
-12% -$24.7K ﹤0.01% 1511
2024
Q2 		$233K Buy
68,000
+14,000
+26% +$64.2K ﹤0.01% 1451
2024
Q1 		$293K Sell
54,000
-43,276
-44% -$311K ﹤0.01% 1430
2023
Q4 		$527K Buy
97,276
+19,276
+25% +$90.9K ﹤0.01% 1330
2023
Q3 		$686K Buy
+78,000
New +$1.04M ﹤0.01% 1249

Other funds holding SGMT

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $93.4B AUM 35.1% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.71B AUM 374.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return